Strategic Approach to Metabolic Wellness As always, the key is integration, not isolation
many patients stay longer if they need more time for side effects to settle or if progress is still steady
Once key patents expire, Indian companies can launch generics or biosimilars (biologic medicines that are highly similar to the original, with no meaningful difference in safety or effect), provided the Central Drugs Standard Control Organisation (CDSCO) approves them after reviewing quality, safety, and efficacy
Myth: You can see "skin whitening" in 24 hours
Vizient also uses AI to identify variables to be used in its risk models (eg, models that identify drivers of excessive length of stay, mortality, and other outcomes) and, going forward, will employ AI to enhance these models through analysis of unstructured data from electronic health records (before AI, Vizient relied primarily on literature reviews and clinician recommendations to identify variables to test)